General Information of the Compound
| Compound ID |
CP0416698
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
11-[2-[4-[4-[4-[3-[[4-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1,2,5-thiadiazol-3-yl]oxy]propyl]piperazin-1-yl]butyl]piperidin-1-yl]acetyl]-5H-benzo[b][1,4]benzodiazepin-6-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C39H52N8O3S
|
||||||||||||||||||
| Molecular Weight |
712.965
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC(=CC1)c1nsnc1OCCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc34)CC2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C39H52N8O3S/c1-43-20-16-31(17-21-43)37-39(42-51-41-37)50-28-8-19-45-26-24-44(25-27-45)18-7-6-9-30-14-22-46(23-15-30)29-36(48)47-34-12-4-2-10-32(34)38(49)40-33-11-3-5-13-35(33)47/h2-5,10-13,16,30H,6-9,14-15,17-29H2,1H3,(H,40,49)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XFGSFWFIJFNGQY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT01198, Muscarinic acetylcholine receptor M2
Protein ID: PT01266, Muscarinic acetylcholine receptor M3
Protein ID: PT01156, Muscarinic acetylcholine receptor M4
Protein ID: PT01516, Muscarinic acetylcholine receptor M5